Cargando…
TNF-α Production by Monocytes Stimulated With Epstein-Barr Virus–Peptides as a Marker of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients
INTRODUCTION: Infections and cancers now outnumber rejection as a cause of morbidity in transplant recipients, likely as a result of over-immunosuppression. Currently, there is no clinical tool to detect over-immunosuppression. We recently reported that tumor necrosis factor alpha (TNF-α) production...
Autores principales: | Bouchard-Boivin, François, Désy, Olivier, Béland, Stéphanie, Houde, Isabelle, De Serres, Sacha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829185/ https://www.ncbi.nlm.nih.gov/pubmed/31701054 http://dx.doi.org/10.1016/j.ekir.2019.07.007 |
Ejemplares similares
-
Epstein–Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis
por: Isobe, Y, et al.
Publicado: (2008) -
Epstein-Barr Virus–Positive Mucocutaneous Ulcer in an Immunosuppressed Patient
por: Hujoel, Isabel A., et al.
Publicado: (2018) -
Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype
por: Désy, Olivier, et al.
Publicado: (2018) -
A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
por: Cho, Hyun-Il, et al.
Publicado: (2018) -
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
por: Zheng, Xueyi, et al.
Publicado: (2022)